Related Experiment Video

Updated: Aug 8, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

Chronic hepatitis C viral infection in patients with normal serum alanine aminotransferases

A M Di Bisceglie1

  • 1Department of Internal Medicine, Saint Louis University School of Medicine, Missouri 63104, USA.

The American Journal of Medicine
|February 1, 2000
PubMed

Insights

Many chronic hepatitis C virus (HCV) patients with normal ALT levels remain untreated. A small study showed a 33% sustained response to interferon/ribavirin, indicating a need for better therapies.

Area of Science:

  • Hepatology
  • Virology
  • Clinical Medicine

Background:

  • A significant number of patients with chronic hepatitis C virus (HCV) infection exhibit persistently normal serum alanine aminotransferases (ALT).
  • These patients present a therapeutic challenge due to unclear treatment guidelines and low response rates to interferon monotherapy.
  • Interferon therapy has, in some instances, led to elevated serum aminotransferases, complicating treatment decisions.

Purpose of the Study:

  • To evaluate the efficacy of interferon and ribavirin combination therapy in patients with chronic hepatitis C virus infection and persistently normal serum ALT.
  • To address the therapeutic dilemma posed by this patient subgroup.

Main Methods:

  • A cohort of 24 patients with normal ALT levels and chronic HCV infection were treated with a combination of interferon and ribavirin.
  • Patient outcomes were assessed, focusing on sustained virologic response.

Main Results:

  • Preliminary analysis indicated a 33% sustained response rate at 24 weeks post-therapy in the treated group.
  • This response rate suggests potential, but highlights limitations of current therapies for this specific HCV population.

Conclusions:

  • Current therapies, including interferon/ribavirin, offer limited efficacy for chronic hepatitis C virus patients with normal ALT levels.
  • Further research into more effective and better-tolerated treatments is warranted to effectively manage and potentially eradicate chronic HCV infection in this cohort.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride (CCl4) Exposure Through an Orogastric Tube

Published on: April 28, 2020

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...